MARKET

LENZ

LENZ

LENZ THERAPEUTICS INC
NASDAQ
26.72
-1.18
-4.23%
After Hours: 26.71 -0.01 -0.04% 19:56 12/05 EST
OPEN
27.70
PREV CLOSE
27.90
HIGH
28.11
LOW
26.65
VOLUME
396.63K
TURNOVER
--
52 WEEK HIGH
50.40
52 WEEK LOW
16.54
MARKET CAP
836.07M
P/E (TTM)
-12.6833
1D
5D
1M
3M
1Y
5Y
1D
Lenz Therapeutics: A Close Look
Seeking Alpha · 2d ago
Lenz Therapeutics announces MFDS submission of NDA for LNZ100
TipRanks · 4d ago
LENZ Therapeutics And Lotus Pharmaceutical Announces That Lotus Has Submitted A New Drug Application To South Korea's Ministry Of Food And Drug Safety For Vizz, Intended To Treat Presbyopia In Adults
Benzinga · 4d ago
Lenz Therapeutics Announces Licensing Agreement Milestone With Lotus for VIZZ in South Korea and Southeast Asia
Reuters · 4d ago
LENZ THERAPEUTICS ANNOUNCES MFDS SUBMISSION OF NEW DRUG APPLICATION FOR LNZ100 (VIZZ™) IN SOUTH KOREA FOR THE TREATMENT OF PRESBYOPIA
Reuters · 4d ago
3 Best Stocks to Buy Now, 12/1/2025, According to Top Analysts
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), LENZ Therapeutics (LENZ) and Teva Pharmaceutical (TEVA)
TipRanks · 4d ago
Weekly Report: what happened at LENZ last week (1124-1128)?
Weekly Report · 4d ago
More
About LENZ
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.

Webull offers Lenz Therapeutics Inc stock information, including NASDAQ: LENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LENZ stock methods without spending real money on the virtual paper trading platform.